BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy4747
(414 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2I53|A Chain A, Crystal Structure Of Cyclin K
Length = 258
Score = 375 bits (962), Expect = e-104, Method: Compositional matrix adjust.
Identities = 172/240 (71%), Positives = 207/240 (86%), Gaps = 1/240 (0%)
Query: 39 TMPYWYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFH 98
T P WY+DKKD+ ++PS EG+D TE RYRREGARFI D GT++ L Y+T+ATG+++FH
Sbjct: 11 TKPCWYWDKKDLAHTPSQLEGLDPATEARYRREGARFIFDVGTRLGLHYDTLATGIIYFH 70
Query: 99 RFYMYHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVDDKKFKTFGDDPREE 158
RFYM+HSFK FPRYVT +CCLFLAGKVEETPKKCKD+IKTAR L++D +F FGDDP+EE
Sbjct: 71 RFYMFHSFKQFPRYVTGACCLFLAGKVEETPKKCKDIIKTARSLLNDVQFGQFGDDPKEE 130
Query: 159 VMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSLCTTLCL 218
VM LERILLQTIKFDLQV+HPY FLLKYAK LKGDK K++K++QMAWTFVNDSLCTTL L
Sbjct: 131 VMVLERILLQTIKFDLQVEHPYQFLLKYAKQLKGDKNKIQKLVQMAWTFVNDSLCTTLSL 190
Query: 219 QWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVLDLY 278
QWEPEIIAVA+MYLAG+L KFE+ +W + + RWWE FV+D+ +D+LEDICHQ+LDLY
Sbjct: 191 QWEPEIIAVAVMYLAGRLCKFEIQEWTSK-PMYRRWWEQFVQDVPVDVLEDICHQILDLY 249
>pdb|3TNH|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|B Chain B, Structure Of Cdk9CYCLIN T F241L
Length = 259
Score = 151 bits (381), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 16/242 (6%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFHRFYM 102
WYF ++ + NSPS R G+D + E YR++ A + D G ++++ T+ T +V+ HRFYM
Sbjct: 12 WYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYM 71
Query: 103 YHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVD------DKKFKTFGDDPR 156
SF FP A LFLA KVEE PKK + VIK A + D + + + +
Sbjct: 72 IQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQ 131
Query: 157 EEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSL-CTT 215
+ V+ LE I+LQT+ F+L +DHP++ ++K + ++ K + Q ++ +SL TT
Sbjct: 132 DLVI-LESIILQTLGFELTIDHPHTHVVKCTQLVRASK----DLAQTSYFMATNSLHLTT 186
Query: 216 LCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVL 275
LQ+ P ++A ++LA K S +E+ + + KH WWE +T++LL+++ H++L
Sbjct: 187 FSLQYTPPVVACVCIHLACKWSNWEIP--VSTDGKH--WWEYVDATVTLELLDELTHELL 242
Query: 276 DL 277
+
Sbjct: 243 QI 244
>pdb|3MI9|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 266
Score = 150 bits (378), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 138/242 (57%), Gaps = 16/242 (6%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFHRFYM 102
WYF ++ + NSPS R G+D + E YR++ A + D G ++++ T+ T +V+ HRFYM
Sbjct: 12 WYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYM 71
Query: 103 YHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVD------DKKFKTFGDDPR 156
SF FP A LFLA KVEE PKK + VIK A + D + + + +
Sbjct: 72 IQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQ 131
Query: 157 EEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSL-CTT 215
+ V+ LE I+LQT+ F+L +DHP++ ++K + ++ K + Q ++ +SL TT
Sbjct: 132 DLVI-LESIILQTLGFELTIDHPHTHVVKCTQLVRASK----DLAQTSYFMATNSLHLTT 186
Query: 216 LCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVL 275
LQ+ P ++A ++LA K S +E+ + + KH WWE +T++LL+++ H+ L
Sbjct: 187 FSLQYTPPVVACVCIHLACKWSNWEIP--VSTDGKH--WWEYVDATVTLELLDELTHEFL 242
Query: 276 DL 277
+
Sbjct: 243 QI 244
>pdb|2PK2|A Chain A, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|B Chain B, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|C Chain C, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|D Chain D, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
Length = 358
Score = 149 bits (376), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 138/242 (57%), Gaps = 16/242 (6%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFHRFYM 102
WYF ++ + NSPS R G+D + E YR++ A + D G ++++ T+ T +V+ HRFYM
Sbjct: 12 WYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYM 71
Query: 103 YHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVD------DKKFKTFGDDPR 156
SF FP A LFLA KVEE PKK + VIK A + D + + + +
Sbjct: 72 IQSFTRFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQ 131
Query: 157 EEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSL-CTT 215
+ V+ LE I+LQT+ F+L +DHP++ ++K + ++ K + Q ++ +SL TT
Sbjct: 132 DLVI-LESIILQTLGFELTIDHPHTHVVKCTQLVRASK----DLAQTSYFMATNSLHLTT 186
Query: 216 LCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVL 275
LQ+ P ++A ++LA K S +E+ + + KH WWE +T++LL+++ H+ L
Sbjct: 187 FSLQYTPPVVACVCIHLACKWSNWEIP--VSTDGKH--WWEYVDATVTLELLDELTHEFL 242
Query: 276 DL 277
+
Sbjct: 243 QI 244
>pdb|2W2H|A Chain A, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
pdb|2W2H|B Chain B, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
Length = 264
Score = 149 bits (375), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 138/242 (57%), Gaps = 16/242 (6%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFHRFYM 102
WYF ++ + NSPS R G+D + E YR++ A + D G ++++ T+ T +V+ HRFYM
Sbjct: 9 WYFTREQLENSPSRRFGLDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYM 68
Query: 103 YHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVD------DKKFKTFGDDPR 156
SF F R A LFLA KVEE PKK + VIK A + D + + + +
Sbjct: 69 IQSFTRFHRNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQ 128
Query: 157 EEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSL-CTT 215
+ V+ LE I+LQT+ F+L +DHP++ ++K + ++ K + Q ++ +SL TT
Sbjct: 129 DLVI-LESIILQTLGFELTIDHPHTHVVKCTQLVRASK----DLAQTSYFMATNSLHLTT 183
Query: 216 LCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVL 275
LQ+ P ++A ++LA K S +E+ + + KH WWE +T++LL+++ H+ L
Sbjct: 184 FSLQYTPPVVACVCIHLACKWSNWEIP--VSTDGKH--WWEYVDATVTLELLDELTHEFL 239
Query: 276 DL 277
+
Sbjct: 240 QI 241
>pdb|2IVX|A Chain A, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
pdb|2IVX|B Chain B, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
Length = 257
Score = 148 bits (374), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 80/242 (33%), Positives = 141/242 (58%), Gaps = 16/242 (6%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFHRFYM 102
W+F ++ + N+PS R G++ + E R++ A I + G ++++ T+ T +V+ HRFYM
Sbjct: 5 WFFTREQLENTPSRRCGVEADKELSCRQQAANLIQEMGQRLNVSQLTINTAIVYMHRFYM 64
Query: 103 YHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVD------DKKFKTFGDDPR 156
+HSF F + + +S LFLA KVEE +K + VIK A + D K + R
Sbjct: 65 HHSFTKFNKNIISSTALFLAAKVEEQARKLEHVIKVAHACLHPLEPLLDTKCDAYLQQTR 124
Query: 157 EEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSL-CTT 215
E V+ LE I+LQT+ F++ ++HP++ ++K + ++ K + Q ++ +SL TT
Sbjct: 125 ELVI-LETIMLQTLGFEITIEHPHTDVVKCTQLVRASK----DLAQTSYFMATNSLHLTT 179
Query: 216 LCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVL 275
CLQ++P +IA ++LA K S +E+ + + KH WWE +T++LL+++ H+ L
Sbjct: 180 FCLQYKPTVIACVCIHLACKWSNWEIP--VSTDGKH--WWEYVDPTVTLELLDELTHEFL 235
Query: 276 DL 277
+
Sbjct: 236 QI 237
>pdb|3BLH|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|B Chain B, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|B Chain B, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|4EC8|B Chain B, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|B Chain B, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
pdb|4BCF|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCH|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 260
Score = 148 bits (373), Expect = 6e-36, Method: Compositional matrix adjust.
Identities = 82/242 (33%), Positives = 138/242 (57%), Gaps = 16/242 (6%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARFIIDCGTKMDLGYNTMATGVVFFHRFYM 102
WYF ++ + NSPS R G+D + E YR++ A + D G ++++ T+ T +V+ HRFYM
Sbjct: 13 WYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYM 72
Query: 103 YHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVD------DKKFKTFGDDPR 156
SF FP A LFLA KVE PKK + VIK A + D + + + +
Sbjct: 73 IQSFTRFPGNSVAPAALFLAAKVEGQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQ 132
Query: 157 EEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSL-CTT 215
+ V+ LE I+LQT+ F+L +DHP++ ++K + ++ K + Q ++ +SL TT
Sbjct: 133 DLVI-LESIILQTLGFELTIDHPHTHVVKCTQLVRASK----DLAQTSYFMATNSLHLTT 187
Query: 216 LCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNSKHLRWWEMFVEDMTMDLLEDICHQVL 275
LQ+ P ++A ++LA K S +E+ + + KH WWE +T++LL+++ H++L
Sbjct: 188 FSLQYTPPVVACVCIHLACKWSNWEIP--VSTDGKH--WWEYVDATVTLELLDELTHELL 243
Query: 276 DL 277
+
Sbjct: 244 QI 245
>pdb|3RGF|B Chain B, Crystal Structure Of Human Cdk8CYCC
Length = 285
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 43 WYFDKKDIRNSPSFREGIDYETEQRYRREGARF---IIDCGTKMDLGYNTMATGVVFFHR 99
W DK+D+ ++ + + +E+ Y + F I G + L +AT V+F R
Sbjct: 16 WILDKQDLLKER--QKDLKFLSEEEYWKLQIFFTNVIQALGEHLKLRQQVIATATVYFKR 73
Query: 100 FYMYHSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVDDKKFKTFGDDPRE-- 157
FY +S K+ + A C+FLA KVEE + A V +F P+E
Sbjct: 74 FYARYSLKSIDPVLMAPTCVFLASKVEEFGVVSNTRLIAAATSVLKTRFSYAF--PKEFP 131
Query: 158 ----EVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEKMLQMAWTFVNDSLC 213
++ E LL+ + L V HPY LL+Y + D + + +L +AW VND+
Sbjct: 132 YRMNHILECEFYLLELMDCCLIVYHPYRPLLQYVQ----DMGQEDMLLPLAWRIVNDTYR 187
Query: 214 TTLCLQWEPEIIAVALMYLAGKLSKFEVVDWIGRNS 249
T LCL + P +IA+A +++A + + + W S
Sbjct: 188 TDLCLLYPPFMIALACLHVACVVQQKDARQWFAELS 223
>pdb|1ZP2|A Chain A, Structure Of The Mediator Subunit Cyclin C
Length = 235
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 80 GTKMDLGYNTMATGVVFFHRFYMY-HSFKTFPRYVTASCCLFLAGKVEETPKKCKDVIKT 138
G ++ L +AT +V R+ + + K F + C++L+ KVEE P + +
Sbjct: 39 GDRLRLRQRVLATAIVLLRRYMLKKNEEKGFSLEALVATCIYLSCKVEECPVHIRTICNE 98
Query: 139 ARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLE 198
A L K R + +E ++ + L V HPY+ L + D +
Sbjct: 99 ANDLWSLK-----VKLSRSNISEIEFEIISVLDAFLIVHHPYTSL----EQAFHDGIINQ 149
Query: 199 KMLQMAWTFVNDSLCTTLCLQWEPEIIAVALMYLA 233
K L+ AW+ VNDS ++LCL P +A A + ++
Sbjct: 150 KQLEFAWSIVNDSYASSLCLMAHPHQLAYAALLIS 184
>pdb|1KXU|A Chain A, Cyclin H, A Positive Regulatory Subunit Of Cdk Activating
Kinase
Length = 333
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 88 NTMATGVVFFHRFYMYHSFKTF-PRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVDDK 146
+ + T ++F RFY+ +S + PR + +C FLA KV+E + + + + + +
Sbjct: 88 SVVGTACMYFKRFYLNNSVMEYHPRIIMLTCA-FLACKVDEFN------VSSPQFVGNLR 140
Query: 147 KFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEK---MLQM 203
+ + E+++ E +L+Q + F L V +PY + LK LE + +
Sbjct: 141 ESPLGQEKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKTRYPILENPEILRKT 200
Query: 204 AWTFVNDSLCTTLCLQWEPEIIAV 227
A F+N T L + P IA+
Sbjct: 201 ADDFLNRIALTDAYLLYTPSQIAL 224
>pdb|1JKW|A Chain A, Structure Of Cyclin Mcs2
Length = 323
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 88 NTMATGVVFFHRFYMYHSFKTF-PRYVTASCCLFLAGKVEETPKKCKDVIKTARMLVDDK 146
+ + T ++F RFY+ +S + PR + +C FLA KV+E + + + + + +
Sbjct: 78 SVVGTACMYFKRFYLNNSVMEYHPRIIMLTCA-FLACKVDEFN------VSSPQFVGNLR 130
Query: 147 KFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGDKTKLEK---MLQM 203
+ + E+++ E +L+Q + F L V +PY + LK LE + +
Sbjct: 131 ESPLGQEKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKTRYPILENPEILRKT 190
Query: 204 AWTFVNDSLCTTLCLQWEPEIIAV 227
A F+N T L + P IA+
Sbjct: 191 ADDFLNRIALTDAYLLYTPSQIAL 214
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 46 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 105
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD T+ +++V+ +E ++L+ + FDL FL +Y L+
Sbjct: 106 EFV----YITDD----TYS---KKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPA 154
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 155 NCKVES---LAMFLGELSLIDADPYLKYLPSLIAGAAFHLA 192
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 43 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 102
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD T+ +++V+ +E ++L+ + FDL FL +Y L+
Sbjct: 103 EFV----YITDD----TYS---KKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPA 151
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 152 NCKVES---LAMFLGELSLIDADPYLKYLPSLIAGAAFHLA 189
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 43 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 102
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD T+ +++V+ +E ++L+ + FDL FL +Y L+
Sbjct: 103 EFV----YITDD----TYS---KKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPA 151
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 152 NCKVES---LAMFLGELSLIDADPYLKYLPSLIAGAAFHLA 189
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLCTTLCLQWEPEIIAVALMYLA 233
K+E + + L++ P +IA A +LA
Sbjct: 156 NCKVESLAMFLGEL--SLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 32.7 bits (73), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 32.7 bits (73), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLCTTLCLQWEPEIIAVALMYLA 233
K+E + + L++ P +IA A +LA
Sbjct: 156 NCKVESLAMFLGEL--SLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 32.7 bits (73), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 47 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 107 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 155
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 156 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAAAAFHLA 193
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 32.3 bits (72), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 50 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 109
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 110 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 158
Query: 194 KTKLEKMLQMAWTFVNDSLCTTLCLQWEPEIIAVALMYLA 233
K+E + + L++ P +IA A +LA
Sbjct: 159 NCKVESLAMFLGEL--SLIDADPYLKYLPSVIAGAAFHLA 196
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 31.6 bits (70), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 44 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 103
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 104 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 152
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 153 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAGAAFHLA 190
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 31.6 bits (70), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 45 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 104
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 105 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 153
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 154 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAGAAFHLA 191
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 31.6 bits (70), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 46 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 105
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 106 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 154
Query: 194 KTKLEKMLQMAWTFVNDSLCTTLCLQWEPEIIAVALMYLA 233
K+E + + L++ P +IA A +LA
Sbjct: 155 NCKVESLAMFLGEL--SLIDADPYLKYLPSVIAGAAFHLA 192
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 31.6 bits (70), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 43 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 102
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 103 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 151
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 152 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAGAAFHLA 189
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 31.6 bits (70), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 43 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 102
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 103 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 151
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 152 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAGAAFHLA 189
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 31.6 bits (70), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 45 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 104
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 105 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 153
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 154 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAGAAFHLA 191
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 31.2 bits (69), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 16/161 (9%)
Query: 75 FIIDCGTKMDLGYNTMATGVVFFHRFYMYHSFKTFPRYVTASCCLFLAGKVEET-PKKCK 133
++++ G + L T+ V + RF S + + + LA K EE P +
Sbjct: 41 WLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 100
Query: 134 DVIKTARMLVDDKKFKTFGDDPREEVMTLERILLQTIKFDLQVDHPYSFLLKYAKSLKGD 193
+ + + DD K ++V+ +E ++L+ + FDL FL +Y +
Sbjct: 101 EFV----YITDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPA 149
Query: 194 KTKLEKMLQMAWTFVNDSLC-TTLCLQWEPEIIAVALMYLA 233
K+E +A SL L++ P +IA A +LA
Sbjct: 150 NCKVES---LAMFLGELSLIDADPYLKYLPSVIAGAAFHLA 187
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.139 0.443
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,865,680
Number of Sequences: 62578
Number of extensions: 383308
Number of successful extensions: 809
Number of sequences better than 100.0: 35
Number of HSP's better than 100.0 without gapping: 11
Number of HSP's successfully gapped in prelim test: 24
Number of HSP's that attempted gapping in prelim test: 781
Number of HSP's gapped (non-prelim): 37
length of query: 414
length of database: 14,973,337
effective HSP length: 101
effective length of query: 313
effective length of database: 8,652,959
effective search space: 2708376167
effective search space used: 2708376167
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 53 (25.0 bits)